Senior Medical Director, Medical Affairs - Immunology

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com . As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit. Job Function: Medical Affairs Group Job Sub Function: Medical Affairs Job Category: People Leader All Job Posting Locations: Toronto, Ontario, Canada Job Description: We are searching for the best talent for the Senior Medical Director, Medical Affairs - Immunology position to join our Medical Affairs leadership team located in Toronto, Ontario, Canada. About Innovative Medicine Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine Purpose: The Senior Medical Director, Medical Affairs - Immunology provides senior medical, scientific and people leadership for the Canadian Immunology portfolio across gastroenterology, dermatology and rheumatology, including in-line, launch and pipeline assets. The current and emerging portfolio may include Tremfya (guselkumab), Stelara (ustekinumab), icotrokinra, nipocalimab and other Immunology assets as portfolio priorities evolve. The Senior Medical Director, Medical Affairs - Immunology will lead one integrated Immunology Medical Affairs strategy and execution plan across Medical Strategy, Evidence Generation, Field Medical, Medical Education and Medical Communications. The Senior Medical Director, Medical Affairs - Immunology will ensure that activities address a clearly defined patient, healthcare-system or scientific need, are prioritized to the highest-impact opportunities and are measured for outcomes, not only activity completion. The Senior Medical Director, Medical Affairs - Immunology will serve as a member of the Medical Affairs Leadership Team (MALT), contributing beyond Immunology to the strategic direction, governance, capability building and performance of Medical Affairs Canada. Represent Canada in relevant regional and Global Medical Affairs Teams (GMATs), worldwide evidence planning and other global forums, shaping strategy with Canadian clinical-practice, access and healthcare-system needs. The Senior Medical Director, Medical Affairs - Immunology will build trusted scientific partnerships with external experts, professional societies, patient organizations and other healthcare stakeholders, while maintaining clear medical independence and compliance with applicable laws, regulations, industry codes and J&J policies. You will be responsible for: Immunology strategy, portfolio and launch leadership: Own the end-to-end Canadian Medical Affairs strategy for Immunology and ensure alignment across gastroenterology, dermatology and rheumatology disease areas, asset life cycles and pipeline priorities. Translate business, scientific, patient and healthcare-system needs into a small number of clear medical priorities, critical deliverables, resource choices and measurable outcomes. Provide medical leadership for launch readiness, indication expansion, lifecycle management, prioritization and scenario planning, including clear recommendations when evidence, regulatory, access or investment assumptions change. Provide senior medical leadership within cross-functional teams, partnering closely with Commercial, Market Access, Regulatory, Clinical Operations, Patient Engagement, Legal, Privacy, HCC/Compliance and Finance while preserving Medical Affairs accountability and independence. Evidence generation and scientific dissemination: Lead the Canadian Integrated Evidence Generation Plan (IEGP), integrating local, regional and worldwide evidence needs and prioritizing studies that can materially inform clinical practice, guidelines, access, safe use or scientific differentiation. Oversee local interventional and non-interventional studies, real-world evidence, investigator-initiated studies, collaborative research, data-source opportunities and publication plans, with fit-for-purpose design, appropriate governance, feasibility, budget discipline and timely dissemination. Ensure study concepts and protocols address a defined evidence gap, have a clear path to impact, and are scientifically and operationally rigorous. Provide medical assessment and approval of local protocols within delegated authority. Connect Canadian evidence priorities to global teams early, advocate for Canadian inclusion in multi-country studies and ensure local insights shape worldwide plans. Support high-quality abstracts, manuscripts, congress communications and scientific platforms. Field Medical and external scientific engagement: Set direction for the Immunology Field Medical strategy and ensure MSL plans, stakeholder segmentation, scientific narratives, insight collection and execution are aligned to the integrated medical plan. Partner closely with the Associate Director, Field Medical to establish consistent expectations, coaching, scientific capability, performance measures and compliant ways of working across IBD, dermatology and rheumatology field teams. Maintain direct, credible engagement with priority Canadian experts and institutions. Personally participate in customer interactions, advisory boards, congresses and other scientific exchanges to understand evolving practice and test strategic assumptions. Ensure insights are synthesized into actionable recommendations and visibly influence evidence generation, education, communications, launch plans and resource allocation. Medical Education and Medical Communications: Own strategic integration of Medical Education and Medical Communications into the Immunology medical plan, while leveraging the specialist expertise of NMEM and Medical Communications colleagues for compliant design and execution. Ensure educational initiatives are grounded in documented learning needs, define the priority audience and intended change, use appropriate channels and include meaningful outcome measures. <